A review of evidence on a range of effective interventions to reduce the risk of HIV transmission among people who inject drugs.
Research Update: Youth Who Use Drugs Who Cannot Access Addiction Treatment Are Twice as Likely to Start Injecting
Researchers found that youth who used cocaine, crack, heroin or methamphetamines, but who had never injected, were twice as likely to start injecting after being unable to access addiction treatment.
David Fawcett, Ph.D., L.C.S.W. admits he was a bit shocked by seeing rainbow-colored syringe packs, but asks, "Can we really afford not to utilize every tool we have to prevent HIV and HCV?"
Methamphetamine use significantly boosted a sexual risk score that predicts HIV acquisition in a study of 8,905 U.S. men who have sex with men.
Sexual risk behavior increased significantly among men who have sex with men when they started using meth, reports a study published recently.
Needle exchanges could receive a financial boost this year following a decision by Congress to lift a ban on federal funding. As abuse of prescription drugs and opiates continues to spread across the nation, more states are considering exchanges as a...
Recreational Drug Use Associated With Increased High-Risk Sexual Behaviors Among Young Gay Men Living With HIV
Intense recreational drug use and high-risk sex are strongly linked in young HIV-infected MSM (men who have sex with men). This may have negative impacts on treatment adherence and virus transmission, requiring targeted harm-reduction advice and supp...
This is the first major study to find that a once-a-day antiretroviral taken by HIV-negative injection drug users can have the same benefits as when pre-exposure prophylaxis (PrEP) is taken to prevent sexual HIV transmission.
iPrEx Welcomes CDC's Bangkok Tenofovir Study Showing Pre-Exposure Prophylaxis (PrEP) Is Safe and Effective for HIV Prevention in Injection Drug Users
Oral PrEP is a critically important HIV prevention tool that can play a significant role in reducing individual infection risk and helping to end the epidemic. Today's news, that PrEP prevents HIV among people whose primary infection risk is injectio...
Daily oral PrEP (pre-exposure prophylaxis) with a tablet containing tenofovir disoproxil fumarate (tenofovir, marketed in the United States under the brand name Viread®) was found to reduce the risk of acquiring HIV by approximately 49 perce...